PURPOSE: To investigate whether oligodendroglial tumors with or without 1p/19q loss differ in their diffusion-weighted imaging characteristics. Oligodendroglial tumors with or without 1p/19q loss differ in their therapeutic responsiveness and prognosis, and recent reports also suggest that these tumors may differ in their magnetic resonance characteristics and blood volume. MATERIALS AND METHODS: Apparent diffusion coefficients (ADCs) were assessed in three grade II oligodendrogliomas, nine grade II and five grade III oligoastrocytomas with known 1p/19q status. Regions of interest (ROIs) were placed on ADC maps: 1) around tumor margins to generate pixel histograms; 2) over minimum and maximum tumor ADC; 3) on areas comparable to the highest choline (Cho)/creatine (Cr) ratio determined from chemical shift imaging (CSI); and 4) across tumor margins to measure the ADC transition coefficient (ATC). RESULTS: Tumor ADC was significantly different from normal brain (P < 0.001). ADC in regions of highest Cho/Cr was greater than minimum ADC and did not correlate with the Cho/Cr ratio. ADC and ATC were not significantly different between oligodendroglial subtypes or grades. Tumors with intact 1p/19q had higher maximum (P = 0.021) and histogram ADC (P = 0.015), and greater ATC (P = 0.001) compared to those with 1p/19q loss, which may reflect differences in edema and cellularity. CONCLUSION: This preliminary study identified differences in ADC and ATC between oligodendroglial tumor genotypes that may reflect underlying biology. Confirmation in a larger series is warranted. (c) 2007 Wiley-Liss, Inc.
PURPOSE: To investigate whether oligodendroglial tumors with or without 1p/19q loss differ in their diffusion-weighted imaging characteristics. Oligodendroglial tumors with or without 1p/19q loss differ in their therapeutic responsiveness and prognosis, and recent reports also suggest that these tumors may differ in their magnetic resonance characteristics and blood volume. MATERIALS AND METHODS: Apparent diffusion coefficients (ADCs) were assessed in three grade II oligodendrogliomas, nine grade II and five grade III oligoastrocytomas with known 1p/19q status. Regions of interest (ROIs) were placed on ADC maps: 1) around tumor margins to generate pixel histograms; 2) over minimum and maximum tumor ADC; 3) on areas comparable to the highest choline (Cho)/creatine (Cr) ratio determined from chemical shift imaging (CSI); and 4) across tumor margins to measure the ADC transition coefficient (ATC). RESULTS:Tumor ADC was significantly different from normal brain (P < 0.001). ADC in regions of highest Cho/Cr was greater than minimum ADC and did not correlate with the Cho/Cr ratio. ADC and ATC were not significantly different between oligodendroglial subtypes or grades. Tumors with intact 1p/19q had higher maximum (P = 0.021) and histogram ADC (P = 0.015), and greater ATC (P = 0.001) compared to those with 1p/19q loss, which may reflect differences in edema and cellularity. CONCLUSION: This preliminary study identified differences in ADC and ATC between oligodendroglial tumor genotypes that may reflect underlying biology. Confirmation in a larger series is warranted. (c) 2007 Wiley-Liss, Inc.
Authors: Min Kyoung Lee; Ji Eun Park; Youngheun Jo; Seo Young Park; Sang Joon Kim; Ho Sung Kim Journal: Eur Radiol Date: 2019-08-24 Impact factor: 5.315
Authors: S Fellah; D Caudal; A M De Paula; P Dory-Lautrec; D Figarella-Branger; O Chinot; P Metellus; P J Cozzone; S Confort-Gouny; B Ghattas; V Callot; N Girard Journal: AJNR Am J Neuroradiol Date: 2012-12-06 Impact factor: 3.825
Authors: Wei Bian; Inas S Khayal; Janine M Lupo; Colleen McGue; Scott Vandenberg; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Sarah J Nelson Journal: Transl Oncol Date: 2009-12 Impact factor: 4.243
Authors: J H Harreld; S N Hwang; I Qaddoumi; R G Tatevossian; X Li; J Dalton; K Haupfear; Y Li; D W Ellison Journal: AJNR Am J Neuroradiol Date: 2016-07-28 Impact factor: 3.825
Authors: Susan M Chang; Sarah Nelson; Scott Vandenberg; Soonmee Cha; Michael Prados; Nicholas Butowski; Michael McDermott; Andrew T Parsa; Manish Aghi; Jennifer Clarke; Mitchel Berger Journal: J Neurooncol Date: 2009-04-09 Impact factor: 4.130
Authors: Michael D Jenkinson; Daniel G du Plessis; Trevor S Smith; Andrew R Brodbelt; Kathy A Joyce; Carol Walker Journal: J Neurooncol Date: 2009-07-19 Impact factor: 4.130